AN IN VITRO COST-EFFECTIVE TEST BENCH FOR ACTIVE CARDIAC IMPLANTS, REPRODUCING HUMAN EXPOSURE TO ELECTRIC FIELDS 50 HZ

The European Directive 2013/35/UE sets the minimum requirements for the protection of workers exposed to electromagnetic fields and defines workers bearing implants as workers at particular risk. The European standards 50527-1 and 50527-2-1 propose risk assessments methods for these workers, including numerical and/or experimental in-vitro approaches. This study aims to conceive by using both methods, a cost-effective test bench for active cardiac implants in order to reproduce induced phenomena on a cardiac implant inside a human exposed to 50 Hz electric field, representing exposure up to 100 kV/m, which covers occupational exposure.

[1]  Daniel R. Frisch,et al.  Implantation Trends and Patient Profiles for Pacemakers and Implantable Cardioverter Defibrillators in the United States: 1993–2006 , 2010, Pacing and clinical electrophysiology : PACE.

[2]  R. Findlay.  Induced electric fields in the MAXWEL surface-based human model from exposure to external low frequency electric fields. , 2014, Radiation protection dosimetry.

[3]  Daniel R. Frisch,et al.  Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. , 2012, Journal of the American College of Cardiology.

[4]  Nikolaus Marx,et al.  Electromagnetic Interference With Implantable Cardioverter-Defibrillators at Power Frequency: An In Vivo Study , 2014, Circulation.

[5]  M.A. Stuchly,et al.  Numerical modeling of pacemaker interference in the electric-utility environment , 2005, IEEE Transactions on Device and Materials Reliability.

[6]  Jarmo Elovaara,et al.  Cardiac Pacemakers in Electric and Magnetic Fields of 400‐kV Power Lines , 2012, Pacing and clinical electrophysiology : PACE.

[7]  J. Valentin.  Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.

[8]  K. Jokela,et al.  ICNIRP Guidelines GUIDELINES FOR LIMITING EXPOSURE TO TIME-VARYING , 1998 .

[9]  M. Nadi,et al.  Computation of Pacemakers Immunity to 50 Hz Electric Field: Induced Voltages 10 Times Greater in Unipolar Than in Bipolar Detection Mode , 2017, Bioengineering.

[10]  J.J. Nelson,et al.  Assessment of active implantable medical device interaction in hybrid electric vehicles , 2008, 2008 IEEE International Symposium on Electromagnetic Compatibility.

[11]  Nikolaus Marx,et al.  Effect of lead position and orientation on electromagnetic interference in patients with bipolar cardiovascular implantable electronic devices , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  Thomas Weiland,et al.  A Numerical Method for the Solution of the Eigenwave Problem of Longitudinally Homogeneous Waveguides , 1977 .

[13]  J. Silny,et al.  The influence of anatomical and physiological parameters on the interference voltage at the input of unipolar cardiac pacemakers in low frequency electric fields , 2009, Physics in medicine and biology.

[14]  Mustapha Nadi,et al.  In vitro assessment of the immunity of implantable cardioverter-defibrillators to magnetic fields of 50/60 Hz , 2013, Physiological measurement.

[15]  Jarmo Elovaara,et al.  Implantable Cardioverter Defibrillators in Electric and Magnetic Fields of 400 kV Power Lines , 2014, Pacing and clinical electrophysiology : PACE.

[16]  W. H. Bailey,et al.  Evaluation of biological effects, dosimetric models, and exposure assessment related to ELF electric- and magnetic-field guidelines. , 2001, Applied occupational and environmental hygiene.